BioSpace News Archive

Business

Jacobs Appointed as EPCM Contractor for New Gene Therapy Manufacturing Facility

Under the terms of the contract, Jacobs will perform all required services to design, build and qualify the multi-product facility, which will manufacture gene therapy products upon completion.

January 4, 2018
·
2 min read
Business

Cirius Therapeutics Expands Board of Directors With Appointment of Dennis M. Fenton

Cirius Therapeutics announced today that Dennis Fenton, Ph.D., has been appointed to the company’s board of directors as an independent member.

January 4, 2018
·
2 min read
Business

Pfenex Names Susan A. Knudson as CFO

Pfenex today announced the appointment of Susan A. Knudson as CFO, effective February 1, 2018.

January 4, 2018
·
5 min read
Drug Development

Neuraltus Pharma Announces Completion of Last Patient Visit in Confirmatory Phase II Study of NP001 for the Treatment of Amyotrophic Lateral Sclerosis

The study was conducted to confirm previous Phase 2 findings in ALS patients with elevated levels of systemic inflammation.

January 4, 2018
·
3 min read
Drug Development

Eiger BioPharma Completes Enrollment of Phase II ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients

ULTRA is a randomized, placebo-controlled study designed to evaluate the effects of ubenimex in patients with primary and secondary lymphedema of the lower limb(s).

January 4, 2018
·
5 min read
Business

Servier and Treventis Begin Strategic Research Partnership in Neurodegenerative Diseases

This therapeutic strategy aims to provide patients with a drug that slows the progression of pathology in the brain, thereby minimizing functional decline through a disease-modifying mechanism.

January 4, 2018
·
4 min read
Biotech Beach

Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources

This is the second issued patent for Biocept’s Target Selector assays for molecular analysis using real-time PCR, Sanger sequencing and NGS.

January 4, 2018
·
5 min read
Drug Development

ImmunoGen Announces First Patient Dosed in Phase I Study of IMGN632 for Hematological Malignancies

ImmunoGen today announced that the first patient has been treated with IMGN632 in a Phase 1 clinical trial of patients with CD123-positive hematological malignancies.

January 4, 2018
·
6 min read
Business

Adaptive Biotechnologies Announces Partnership with Microsoft to Decode the Human Immune System to Improve the Diagnosis of Disease

Adaptive Biotechnologies announced today their partnership with Microsoft to map the genetics of the human immune system, or immunome, in order to detect cancers and other diseases in their earliest stage, when they can be more effectively treated.

January 4, 2018
·
4 min read
BioMidwest

Monsanto Spotlights Research & Development Pipeline Projects to Help Farmers Combat Threats, Optimize Opportunities and Conserve Natural Resources

This marks the fifth consecutive year that more than 20 projects advanced in the pipeline.

January 4, 2018
·
12 min read